HS-10374

· Hansoh BioMedical R&D Company

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for HS-10374, covering 2023-12-06 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Drug-Drug Interaction Study Between HS-10374 Tablets and Drospirenone and Ethinyl Estradiol Tablets(Yasmin®) [Phase 1]

See pricing